Suzanne Trudel Selected Research

belantamab mafodotin

4/2024	Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma.
1/2024	Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial.
12/2023	Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial.
11/2021	Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study.
1/2021	Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design.
12/2020	Belantamab mafodotin in the treatment of relapsed or refractory multiple myeloma.
1/2020	Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.
1/2019	Antibody-drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study.
12/2018	Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suzanne Trudel Research Topics

Disease

69	Multiple Myeloma 04/2024 - 03/2004
24	Neoplasms (Cancer) 10/2023 - 05/2004
6	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 08/2008
4	Disease Progression 11/2021 - 08/2008
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 03/2011
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 06/2010
2	Lymphoma (Lymphomas) 02/2017 - 09/2012
2	Thrombocytopenia (Thrombopenia) 02/2015 - 10/2008
2	Hypercholesterolemia 09/2014 - 06/2010
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2012 - 10/2008
2	Leukemia 07/2010 - 08/2008
1	Plasmacytoma 09/2023
1	Plasma Cell Neoplasms 01/2023
1	Amyloidosis 03/2022
1	Hemorrhage 01/2020
1	Mucositis 01/2020
1	Delirium 01/2020
1	Tumor Lysis Syndrome 01/2019
1	Necrosis 12/2018
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2018
1	Testicular Neoplasms (Testicular Cancer) 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017
1	Hypotension (Low Blood Pressure) 08/2015
1	Infections 02/2015
1	Neutropenia 02/2015
1	Plasma Cell Leukemia 01/2015
1	Brain Ischemia (Cerebral Ischemia) 09/2014
1	Immunoglobulin Light-chain Amyloidosis 03/2014

Drug/Important Bio-Agent (IBA)

12	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024 - 03/2013
11	Lenalidomide (CC 5013)FDA Link 09/2023 - 03/2011
11	Bortezomib (Velcade)FDA Link 01/2021 - 10/2008
9	belantamab mafodotinIBA 04/2024 - 12/2018
9	Proteasome InhibitorsIBA 11/2021 - 10/2008
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 12/2005
6	B-Cell Maturation AntigenIBA 01/2024 - 12/2018
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2010
6	Prednisone (Sone)FDA LinkGeneric 01/2016 - 12/2005
6	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2006 - 03/2004
4	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024 - 12/2018
4	carfilzomibIBA 10/2012 - 06/2011
3	Immunomodulating AgentsIBA 11/2021 - 08/2013
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 11/2009
3	Mevalonic Acid (Mevalonate)IBA 01/2021 - 06/2010
3	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 12/2018
3	Tyrosine (L-Tyrosine)FDA Link 03/2015 - 05/2010
3	Phosphotransferases (Kinase)IBA 01/2015 - 11/2006
3	Cyclin D2IBA 04/2011 - 12/2007
2	pomalidomideIBA 01/2024 - 09/2023
2	AntigensIBA 12/2018 - 01/2017
2	Alkylating AgentsIBA 12/2018 - 10/2005
2	PhosphotyrosineIBA 01/2015 - 11/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2014 - 06/2010
2	Protein Isoforms (Isoforms)IBA 04/2013 - 06/2010
2	Thalidomide (Thalomid)FDA Link 04/2013 - 02/2013
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2011 - 08/2011
2	PD 173074IBA 11/2006 - 05/2004
2	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 08/2006 - 04/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2006 - 04/2005
1	pembrolizumabIBA 04/2024
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2023
1	Immunoglobulin Variable RegionIBA 01/2023
1	AntibodiesIBA 12/2022
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2021
1	dostarlimabIBA 01/2021
1	nirogacestatIBA 01/2021
1	Fluvastatin FDA Link 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2021
1	daratumumabIBA 01/2020
1	ElectrolytesIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	isatuximabIBA 12/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	ofatumumab FDA Link 01/2019
1	afuresertibIBA 01/2019
1	Cell Surface ReceptorsIBA 12/2018
1	Immunologic Factors (Immunomodulators)IBA 12/2018
1	monomethylauristatin FIBA 12/2018
1	selinexorIBA 01/2018
1	TTI-621IBA 02/2017
1	EpitopesIBA 01/2016
1	src-Family KinasesIBA 03/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2015
1	Protein Tyrosine PhosphatasesIBA 01/2015
1	Dipyridamole (Persantine)FDA LinkGeneric 09/2014
1	Ciclopirox (Loprox)FDA LinkGeneric 04/2014
1	purineIBA 09/2013
1	Cisplatin (Platino)FDA LinkGeneric 06/2013
1	Etoposide (VP 16)FDA LinkGeneric 06/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2013

Therapy/Procedure

22	Therapeutics 01/2024 - 04/2010
6	Stem Cell Transplantation 12/2018 - 12/2005
3	Drug Therapy (Chemotherapy) 08/2013 - 10/2005
3	Salvage Therapy 06/2013 - 12/2005
1	Autologous Transplantation 11/2023
1	Precision Medicine 01/2023
1	Intravenous Infusions 01/2020
1	Injections 08/2015
1	Drug Tapering 02/2015
1	Cardiopulmonary Resuscitation (CPR) 01/2015